Matthew Stanton
Stock Analyst at Jefferies
(0.60)
# 4,158
Out of 5,113 analysts
7
Total ratings
50%
Success rate
-20.35%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZTA Azenta | Upgrades: Buy | $30 → $38 | $39.03 | -2.64% | 2 | Oct 30, 2025 | |
| RGEN Repligen | Maintains: Hold | $145 → $135 | $160.05 | -15.65% | 1 | Sep 12, 2025 | |
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $9.78 | -18.20% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.43 | +127.27% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $22.94 | -4.10% | 1 | Apr 4, 2024 |
Azenta
Oct 30, 2025
Upgrades: Buy
Price Target: $30 → $38
Current: $39.03
Upside: -2.64%
Repligen
Sep 12, 2025
Maintains: Hold
Price Target: $145 → $135
Current: $160.05
Upside: -15.65%
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $9.78
Upside: -18.20%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.43
Upside: +127.27%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $22.94
Upside: -4.10%